TuisNHIQ • OTCMKTS
add
NantHealth Inc
Vorige sluiting
$0,00010
Dagwisseling
$0,00010 - $0,00010
Markkapitalisasie
2,75 k USD
Gemiddelde volume
187,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Inkomste | 12,47 m | — |
Bedryfskoste | 12,17 m | — |
Netto inkomste | -14,99 m | — |
Netto winsgrens | -120,20 | — |
Wins per aandeel | — | — |
EBITDA | -175,00 k | — |
Effektiewe belastingkoers | -0,36% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 5,82 m | — |
Totale bates | 146,48 m | — |
Totale aanspreeklikheid | 396,66 m | — |
Totale ekwiteit | -250,18 m | — |
Uitstaande aandele | 27,47 m | — |
Prys om te bespreek | -0,00 | — |
Opbrengs op bates | -8,24% | — |
Opbrengs op kapitaal | -41,68% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Netto inkomste | -14,99 m | — |
Kontant van bedrywe | -7,65 m | — |
Kontant van beleggings | 11,00 k | — |
Kontant van finansiering | 7,50 m | — |
Netto kontantverandering | -298,00 k | — |
Beskikbare kontantvloei | -3,94 m | — |
Meer oor
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Gestig
07 Jul. 2010
Webwerf
Werknemers
373